Larry Penn
Analyst · Credit Suisse
Thanks Mark. Our focus 2017 will be on the growth of our loan portfolios. This depends not only on the strength of our pipeline but also on our long financing arrangements. Since the start of 2016 we have added facilities for small balanced commercial loans non-QM mortgage loans, residential NPLs and consumer loans. We tend to be pretty conservative on our use of leverage. But even for our standards, we're still underleveraged. The good news is that we've got lots of free cash in our balance sheet. We've got the ability to free up even more capital as needed. The pipelines of incoming loan assets look good and we already have the financing lines in place. Let's review the status of our loan businesses starting with small balance commercial mortgage loans. These loans which we define as small and they’re under roughly $20 million in size have been a key driver performance like the financial strategy for the past several years. We have a financing line for both distressed loans and the bridge loans that we originate. With this line, we have more room to add assets and what has been our best performing strategy including originating more bridge loans that otherwise might not quite reach our ROE targets. We have an active pipeline of originations and expect that this will be a strong growth area for us going forward. For the next two years we estimate that there are almost $100 billion of CMBS loans originated during the pre-crisis boom that are scheduled to hit balloon payments at their maturity and we expected a significant portion of those will not be able to make those payments. This should provide ample opportunities to add to our portfolio, which as Mark described, is another area where we believe we benefit from significant barriers to entry. These small loans are headaches for banks and special servicers, but opportunities for us. In addition to small balance commercial mortgage loans, the residential NPL markets are ripe with opportunities. And while our loan performance was strong in 2017 in this portfolio, we did it for much of the year without a financing line in place. Sorry, in 2016. Now that that's changed, we have additional room for growth and higher potential returns to boot. We closed on two distressed residential pools in the fourth quarter and expect to continue to ramp up this portfolio. Our CMBS strategy remains, for the time being, to purchase new issue B-pieces. On last quarter's earnings call, just four days before Election Day, we were joined on the call by Leo Huang, our Head CMBS portfolio manager. Leo went into great detail about the risk retention rules that were about to go into effect. However in light of the election results and with the new administration indicating that it will push for significant rollback of Dodd Frank, our focus has stayed for now on our existing highly successful B-piece strategy. We had two B-pieces during the fourth quarter and five B-pieces during 2016. Of course, we'll see how potential changes in legislation play out and we still like to participate in risk retention as the sponsor, should the right opportunity arise. Our consumer loans and ABS strategy was a key area of growth last year and has grown to become the largest strategy in our portfolio at around 21% of credit assets as of year-end, as you can see on slide 12. As Mark mentioned, we now have three origination partners who are performing well for us and we’re in active negotiations to add a new flow agreement. We have financed our consumer loans in a variety of matters and we expect to close on a new loan financing facility very shortly. After we close this new facility, a large majority of our consumer loan portfolio will be under term financing, which will free up even more capital for us to reinvest. In the next two quarters, we could easily add another $50 million to consumer loans to Ellington Financial’s portfolio. Another very interesting area of growth for us is in the reverse mortgage business, where we have a 49% joint venture stake in a growing originator as we described briefly on last quarter's earnings call. The originator continues to progress nicely and they recently hired a great group of loan officers from a competitor, increasing loan officer count by over 50%. Ellington Financial’s objectives for this company are two-fold. First, to help build a significant portfolio of reverse mortgage servicing rights, which we think is a poorly understood asset class that can offer far higher returns than conventional MSRs. And second, for the company to increase retail origination in a space where we think that competition is low, that marginal profits are extremely high and that demographic trends are extremely favorable. And on a related note, our investment in the non-QM originator also is progressing nicely and we are actively monitoring the securitization market for potential issuance after our non-QM portfolio, which was around $72 million at year end, which is critical mass. We are also working on a very interesting opportunity in the CLO space. With CLO risk retention rules taking effect only late last year, new CLO issuance has dramatically declined this year, creating a shortage in a market where demand remains strong. Meanwhile, some of the assets in which we invest, such as higher yielding syndicated bank loans, can be eligible collateral for CLOs. In response, we have begun accumulating certain CLO eligible assets and are exploring ways in which we can access the CLO market to take advantage of high CLO demand and thereby locking favorable long term financing on our portfolio. We believe that very high returns on equity can be generated in this manner, even after expected loss and hedging costs. In summary we see no shortage of opportunities to capital work to grow our loan portfolios. Although there are many components to our loan portfolios, our overall strategy will become more simplified, since the common threat of all of these assets is capturing and leveraging net interest margin. Our stock price significantly lag the peer group in 2016. And to be frank, the main thing we need to do to correct this in 2017 is to deliver on our financial results. Nothing's more important than that. With our corporate credit hedges no longer a significant factor in our portfolio and with our loan portfolios ramping up nicely, we believe that we've finally turned the corner. In the meantime, given the magnitude of the discount to book where our stock was trading for most of the fourth quarter, we repurchased approximately 1% of our outstanding shares during the quarter. Since year-end, our stock price has rebounded by almost a point and we will continue to monitor our price to book ratio when weighing repurchases, recognizing also our need for portfolio growth and earnings growth. Our primary goal remains to generate long-term sustainable earnings for shareholders. This concludes our prepared remarks. And we're now pleased to take your questions. Operator?